Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hemoglobin level within 8.1 to 10.9 gm, patients who are willing to give blood specimen for lab investigation, pallor of skin, mucous membrane, conjunctiva and nail beds, lack of concentration,malaise, anorexia, headache, palpitation
Exclusion criteria
Exclusion criteria: Acute hemorrhagic anemia, patients with chronic disease, known history of Malaise and Dengue fever, any hematological disorder.sickle cell anemia, patient not willing to give blood sample for investigation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of the clinical study will be assessed by increasing the level of Hb before and after treatmentTimepoint: Primary outcome of the clinical study will be assessed by increasing Hb level in before and after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of clinical symptoms like malaise, headache, palpitation, lack of concentration during before and after treatmentTimepoint: Screening - 3 months Patient Enrolment - 3 months Trial Drug - 4 months Data Analysis - 1 month Follow up - 2 month | — |
Countries
India
Contacts
National Institute of Siddha